Nuvasive, Inc. operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nuvasive with three other
companies in this sector in the United States:
Cantel Medical Corp.
sales of $664.76 million
of which 51%
was Endoscope Reprocessing Products),
of which 100%
was Automated Blood), and
Merit Medical Systems, Inc.
of which 96%
Nuvasive reported sales of $962.07 million
December of 2016.
increase of 18.6%
versus 2015, when the company's sales were $811.11 million.
Sales at Nuvasive have increased during each of the previous five years
(and since 2011, sales have increased a total of 78%).